JP2022519409A5 - - Google Patents
Info
- Publication number
- JP2022519409A5 JP2022519409A5 JP2021503582A JP2021503582A JP2022519409A5 JP 2022519409 A5 JP2022519409 A5 JP 2022519409A5 JP 2021503582 A JP2021503582 A JP 2021503582A JP 2021503582 A JP2021503582 A JP 2021503582A JP 2022519409 A5 JP2022519409 A5 JP 2022519409A5
- Authority
- JP
- Japan
- Prior art keywords
- stem cells
- human stem
- mitochondria
- human
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862701783P | 2018-07-22 | 2018-07-22 | |
| US62/701,783 | 2018-07-22 | ||
| PCT/IL2019/050828 WO2020021541A1 (en) | 2018-07-22 | 2019-07-22 | Mitochondrial augmentation therapy with stem cells enriched with functional mitochondria |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022519409A JP2022519409A (ja) | 2022-03-24 |
| JP2022519409A5 true JP2022519409A5 (enExample) | 2022-07-29 |
| JP7633148B2 JP7633148B2 (ja) | 2025-02-19 |
Family
ID=69181398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503582A Active JP7633148B2 (ja) | 2018-07-22 | 2019-07-22 | 機能的ミトコンドリアで富化された幹細胞を用いたミトコンドリア増強療法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20210322485A1 (enExample) |
| EP (1) | EP3823642A4 (enExample) |
| JP (1) | JP7633148B2 (enExample) |
| KR (1) | KR20210035829A (enExample) |
| CN (1) | CN112601532A (enExample) |
| AU (1) | AU2019311862B2 (enExample) |
| BR (1) | BR112021001010A2 (enExample) |
| CA (1) | CA3106188A1 (enExample) |
| IL (1) | IL280162B2 (enExample) |
| MX (1) | MX2021000954A (enExample) |
| WO (1) | WO2020021541A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL282198B2 (en) | 2011-09-11 | 2025-11-01 | Minovia Therapeutics Ltd | Compositions of functional mitochondria and uses thereof |
| US11951135B2 (en) | 2018-07-22 | 2024-04-09 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of muscle diseases |
| EP3823646A4 (en) | 2018-07-22 | 2022-06-08 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of brain diseases |
| WO2020021535A1 (en) | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of ocular diseases |
| AU2019311859B2 (en) | 2018-07-22 | 2025-12-18 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy for primary mitochondrial diseases |
| JP7586811B2 (ja) * | 2018-07-22 | 2024-11-19 | ミノヴィア セラピューティクス リミテッド | 腎臓疾患のミトコンドリア増強療法 |
| EP3823644A4 (en) | 2018-07-22 | 2022-06-08 | Minovia Therapeutics Ltd. | MITOCHONDRIAL AUGMENTATION THERAPY OF PANCREATIC DISEASES |
| TWI857807B (zh) * | 2020-03-20 | 2024-10-01 | 台灣粒線體應用技術股份有限公司 | 含有粒線體之組合物及其用於作為皮膚纖維母細胞活性促進劑之用途 |
| BR112022019609A2 (pt) * | 2020-03-31 | 2022-11-29 | Minovia Therapeutics Ltd | Células geneticamente modificadas enriquecidas com mitocôndrias e usos das mesmas |
| WO2021224920A1 (en) * | 2020-05-05 | 2021-11-11 | Pluristem Ltd. | Methods and compositions for enrichment of target cells |
| AU2022211691A1 (en) * | 2021-01-25 | 2023-08-10 | Minovia Therapeutics Ltd. | Identification of mitochondria-enriched cells |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6472378B2 (en) * | 1998-08-31 | 2002-10-29 | Pro-Neuron, Inc. | Compositions and methods for treatment of mitochondrial diseases |
| US9603872B2 (en) * | 2007-05-02 | 2017-03-28 | The McLeon Hospital Corporation | Methods and compositions for mitochondrial replacement therapy |
| CN102266350A (zh) * | 2011-07-20 | 2011-12-07 | 黄必录 | 逆转干细胞衰老的方案 |
| CN102293178A (zh) * | 2011-08-28 | 2011-12-28 | 黄必录 | 使个体去衰老的方法 |
| CN103976935A (zh) * | 2014-05-28 | 2014-08-13 | 广州市白云区天芳化妆品厂 | 一种抗衰原液及其制备方法 |
| WO2016008937A1 (en) * | 2014-07-16 | 2016-01-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the intercellular transfer of isolated mitochondria in recipient cells |
| TWI707040B (zh) * | 2014-09-11 | 2020-10-11 | 台灣粒線體應用技術股份有限公司 | 一種用於治療退化性神經疾病的細胞、含有該細胞的醫藥組合物及其應用 |
| IL299482B2 (en) * | 2015-02-26 | 2025-02-01 | Minovia Therapeutics Ltd | Mammalian cells are enriched with active mitochondria |
| JP7187036B2 (ja) * | 2016-11-14 | 2022-12-12 | パイアン バイオテクノロジ－ インコーポレイテッド | 外因性ミトコンドリアを細胞内に送達する方法 |
| JP2020502078A (ja) * | 2016-11-30 | 2020-01-23 | パイアン・バイオテクノロジー・インコーポレイテッドＰａｅａｎ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ Ｉｎｃ． | ミトコンドリアを含む医薬組成物 |
-
2019
- 2019-07-22 US US17/252,674 patent/US20210322485A1/en not_active Abandoned
- 2019-07-22 CA CA3106188A patent/CA3106188A1/en active Pending
- 2019-07-22 MX MX2021000954A patent/MX2021000954A/es unknown
- 2019-07-22 AU AU2019311862A patent/AU2019311862B2/en active Active
- 2019-07-22 EP EP19840685.2A patent/EP3823642A4/en active Pending
- 2019-07-22 WO PCT/IL2019/050828 patent/WO2020021541A1/en not_active Ceased
- 2019-07-22 JP JP2021503582A patent/JP7633148B2/ja active Active
- 2019-07-22 BR BR112021001010-6A patent/BR112021001010A2/pt not_active IP Right Cessation
- 2019-07-22 IL IL280162A patent/IL280162B2/en unknown
- 2019-07-22 CN CN201980054078.2A patent/CN112601532A/zh active Pending
- 2019-07-22 KR KR1020217004453A patent/KR20210035829A/ko not_active Ceased
-
2024
- 2024-08-27 US US18/817,206 patent/US20240415894A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022519409A5 (enExample) | ||
| Zhidu et al. | Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities | |
| AU2005248352B2 (en) | Genetically engineered cells for therapeutic applications | |
| Walter et al. | Endothelial progenitor cells: regulation and contribution to adult neovascularization | |
| US12551504B2 (en) | Mitochondrial augmentation therapy of pancreatic diseases | |
| US20240415894A1 (en) | Mitochondrial augmentation therapy with stem cells enriched with functional mitochondria | |
| JP2021532091A5 (enExample) | ||
| ES2575165T3 (es) | Células madre del estroma derivadas de tejido adiposo para su uso en el tratamiento de SRIS | |
| US20030091547A1 (en) | Platelet-derived growth factor protection of cardiac myocardium | |
| KR20230017163A (ko) | 미토콘드리아-풍부화된 유전자 조작 세포 및 이의 용도 | |
| JP2021531284A5 (enExample) | ||
| KR20050000399A (ko) | 줄기세포 및 전구세포 분화의 조절, 측정 및 이들의 용도 | |
| JP2021532094A (ja) | 筋疾患のミトコンドリア増強療法 | |
| TW201130977A (en) | Mesenchymal stem cells (MSCs) isolated from mobilized peripheral blood | |
| JP2021532095A5 (enExample) | ||
| JP2021532095A (ja) | 肝臓疾患のミトコンドリア増強療法 | |
| KR20170021343A (ko) | 패혈증 치료용 중간엽 기질세포 | |
| US20170355959A1 (en) | Methods for mobilising populations of stem cells | |
| Liang et al. | Intravenously Administered Human Umbilical Cord‐Derived Mesenchymal Stem Cell (HucMSC) Improves Cardiac Performance Following Infarction via Immune Modulation | |
| EP1771196B1 (en) | Ccr ligands for stem cell homing | |
| JP2021531281A5 (enExample) | ||
| BRPI0620523A2 (pt) | método de aumentar o potencial de implante e de atração celular, método de preparar células para transplante em um sujeito, população de células e composição farmacêutica | |
| US12385011B2 (en) | Treatment of heart failure and/or post infarct pathological remodeling by ex vivo reprogrammed immune cells | |
| Shichkin | Stem Cells of the Thymus | |
| KR101673318B1 (ko) | 은나노 물질로 처리된 중간엽 줄기세포 또는 그 배양액을 유효성분으로 포함하는 상처 치료용 세포치료제 조성물 |